Jessamyn McKenzie

997 total citations
14 papers, 610 citations indexed

About

Jessamyn McKenzie is a scholar working on Neurology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Jessamyn McKenzie has authored 14 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Neurology. Recurrent topics in Jessamyn McKenzie's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (11 papers) and Alzheimer's disease research and treatments (3 papers). Jessamyn McKenzie is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (11 papers) and Alzheimer's disease research and treatments (3 papers). Jessamyn McKenzie collaborates with scholars based in Canada, United States and Germany. Jessamyn McKenzie's co-authors include Vesna Sossi, A. Jon Stoessl, Michael Schulzer, Matthew J. Farrer, Zbigniew K. Wszołek, Thomas J. Ruth, Nicole Neilson, Nasim Vafai, Elham Shahinfard and Katie Dinelle and has published in prestigious journals such as Brain, Movement Disorders and NeuroImage Clinical.

In The Last Decade

Jessamyn McKenzie

13 papers receiving 602 citations

Peers

Jessamyn McKenzie

NEURO

CMN

PHYSI

NEURO

Mary Ann Thenganatt United States

André R. Troiano Brazil

Prabesh Kanel United States

Vladana Marković Serbia

Katie Dinelle Canada

Sonia Mazzucchi Italy

Heiko Huber Germany

Fusako Yokochi Japan

Valérie Soland Canada

Zahi Qamhawi United Kingdom

Mary Ann Thenganatt United States

Jessamyn McKenzie

687 ×1.4

NEURO

287 ×1.5

CMN

74 ×0.7

PHYSI

73 ×0.8

NEURO

76 ×1.3

Citations per year, relative to Jessamyn McKenzie Jessamyn McKenzie (= 1×) peers Mary Ann Thenganatt

Countries citing papers authored by Jessamyn McKenzie

Since Specialization

Citations

This map shows the geographic impact of Jessamyn McKenzie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessamyn McKenzie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessamyn McKenzie more than expected).

Fields of papers citing papers by Jessamyn McKenzie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessamyn McKenzie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessamyn McKenzie. The network helps show where Jessamyn McKenzie may publish in the future.

Co-authorship network of co-authors of Jessamyn McKenzie

This figure shows the co-authorship network connecting the top 25 collaborators of Jessamyn McKenzie. A scholar is included among the top collaborators of Jessamyn McKenzie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessamyn McKenzie. Jessamyn McKenzie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Matarazzo, Michele, Alexandra Pérez‐Soriano, Nasim Vafai, et al.. (2024). Misfolded protein deposits in Parkinson’s disease and Parkinson’s disease-related cognitive impairment, a [11C]PBB3 study. npj Parkinson s Disease. 10(1). 96–96. 6 indexed citations

Mannheim, Julia G., Jessie Fanglu Fu, Ivan S. Klyuzhin, et al.. (2024). Multi-tracer PET correlation analysis reveals disease-specific patterns in Parkinson’s disease and asymptomatic LRRK2 pathogenic variant carriers compared to healthy controls. NeuroImage Clinical. 42. 103600–103600.

Mannheim, Julia G., Ju-Chieh Cheng, Nasim Vafai, et al.. (2021). Cross-validation study between the HRRT and the PET component of the SIGNA PET/MRI system with focus on neuroimaging. EJNMMI Physics. 8(1). 20–20. 7 indexed citations

Fu, Jessie Fanglu, Michele Matarazzo, Jessamyn McKenzie, et al.. (2020). Serotonergic System Impacts Levodopa Response in Early Parkinson's and Future Risk of Dyskinesia. Movement Disorders. 36(2). 389–397. 13 indexed citations

Fu, Jessie Fanglu, Ivan S. Klyuzhin, Jessamyn McKenzie, et al.. (2019). Joint pattern analysis applied to PET DAT and VMAT2 imaging reveals new insights into Parkinson's disease induced presynaptic alterations. NeuroImage Clinical. 23. 101856–101856. 18 indexed citations

Sacheli, Matthew, Jason L. Neva, Bimal Lakhani, et al.. (2019). Exercise increases caudate dopamine release and ventral striatal activation in Parkinson's disease. Movement Disorders. 34(12). 1891–1900. 126 indexed citations

Fu, Jessie Fanglu, Ivan S. Klyuzhin, Shuying Liu, et al.. (2018). Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET. NeuroImage Clinical. 19. 652–660. 17 indexed citations

Sacheli, Matthew, Danielle Murray, Nasim Vafai, et al.. (2018). Habitual exercisers versus sedentary subjects with Parkinson's Disease: Multimodal PET and fMRI study. Movement Disorders. 33(12). 1945–1950. 39 indexed citations

Pérez‐Soriano, Alexandra, Julieta Arena, Katie Dinelle, et al.. (2017). PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins. Movement Disorders. 32(7). 1016–1024. 59 indexed citations

10.

Wile, Daryl, Katie Dinelle, Nasim Vafai, et al.. (2015). A scan without evidence is not evidence of absence: Scans without evidence of dopaminergic deficit in a symptomatic leucine‐rich repeat kinase 2 mutation carrier. Movement Disorders. 31(3). 405–409. 13 indexed citations

11.

Appel‐Cresswell, Silke, Ali H. Rajput, Vesna Sossi, et al.. (2014). Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism. Movement Disorders. 29(13). 1684–1687. 15 indexed citations

12.

Felício, André C., Katherine Dinelle, Pankaj Agarwal, et al.. (2014). In vivo dopaminergic and serotonergic dysfunction in DCTN1 gene mutation carriers. Movement Disorders. 29(9). 1197–1201. 13 indexed citations

13.

Sossi, Vesna, Raúl de la Fuente‐Fernández, Ramachandiran Nandhagopal, et al.. (2010). Dopamine turnover increases in asymptomatic LRRK2 mutations carriers. Movement Disorders. 25(16). 2717–2723. 88 indexed citations

14.

Adams, John R., Michael Schulzer, Edwin Mak, et al.. (2005). PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation. Brain. 128(12). 2777–2785. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact